Barclays Maintains Equal-Weight on Progyny, Lowers Price Target to $30

Benzinga Newsdesk www.benzinga.com Neutral 70.2%

Neg 0% Neu 70.2% Pos 0%

Barclays analyst Peter Warendorf maintains Progyny (NASDAQ:PGNY) with a Equal-Weight and lowers the price target from $34 to $30.